Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice

Kenta Teruya; Ayumi Oguma; Keita Arai; Keiko Nishizawa; Sara Iwabuchi; Miki Watanabe-Matsui; Yuji Sakasegawa; Hermann Schätzl; Sabine Gilch; Katsumi Doh-ura

doi:10.1016/j.bbrc.2021.04.116

Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice

Kenta Teruya, Ayumi Oguma, Keita Arai, Keiko Nishizawa, Sara Iwabuchi, Miki Watanabe-Matsui, Yuji Sakasegawa, Hermann Schätzl, Sabine Gilch, Katsumi Doh-ura

MED - United Centers for Advanced Research and Translational Medicine (ART)

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Anti-prion effects of cellulose ether (CE) are reported in rodents, but the molecular mechanism is fully unknown. Here, we investigated the genetic background of CE effectiveness by proteomic and genetic analysis in mice. Proteomic analysis in the two mouse lines showing a dramatic difference in CE effectiveness revealed a distinct polymorphism in the glia maturation factor β gene. This polymorphism was significantly associated with the CE effectiveness in various prion-infected mouse lines. Sequencing of this gene and its vicinity genes also revealed several other polymorphisms that were significantly related to the CE effectiveness. These polymorphisms are useful as genetic markers for finding more suitable mouse lines and exploring the genetic factors of CE effectiveness.

Original language	English
Pages (from-to)	105-111
Number of pages	7
Journal	Biochemical and biophysical research communications
Volume	560
DOIs	https://doi.org/10.1016/j.bbrc.2021.04.116
Publication status	Published - 2021 Jun 30

Keywords

Cellulose ether
Genetic analysis
Glia maturation factor
Prion
Proportional hazards model
Proteomics

ASJC Scopus subject areas

Biophysics
Biochemistry
Molecular Biology
Cell Biology

Access to Document

10.1016/j.bbrc.2021.04.116

Cite this

Teruya, K., Oguma, A., Arai, K., Nishizawa, K., Iwabuchi, S., Watanabe-Matsui, M., Sakasegawa, Y., Schätzl, H., Gilch, S., & Doh-ura, K. (2021). Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice. Biochemical and biophysical research communications, 560, 105-111. https://doi.org/10.1016/j.bbrc.2021.04.116

Teruya, K, Oguma, A, Arai, K, Nishizawa, K, Iwabuchi, S, Watanabe-Matsui, M, Sakasegawa, Y, Schätzl, H, Gilch, S & Doh-ura, K 2021, 'Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice', Biochemical and biophysical research communications, vol. 560, pp. 105-111. https://doi.org/10.1016/j.bbrc.2021.04.116

@article{d68b5c421a11480a9d6efac0fdf5feca,

title = "Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice",

abstract = "Anti-prion effects of cellulose ether (CE) are reported in rodents, but the molecular mechanism is fully unknown. Here, we investigated the genetic background of CE effectiveness by proteomic and genetic analysis in mice. Proteomic analysis in the two mouse lines showing a dramatic difference in CE effectiveness revealed a distinct polymorphism in the glia maturation factor β gene. This polymorphism was significantly associated with the CE effectiveness in various prion-infected mouse lines. Sequencing of this gene and its vicinity genes also revealed several other polymorphisms that were significantly related to the CE effectiveness. These polymorphisms are useful as genetic markers for finding more suitable mouse lines and exploring the genetic factors of CE effectiveness.",

keywords = "Cellulose ether, Genetic analysis, Glia maturation factor, Prion, Proportional hazards model, Proteomics",

author = "Kenta Teruya and Ayumi Oguma and Keita Arai and Keiko Nishizawa and Sara Iwabuchi and Miki Watanabe-Matsui and Yuji Sakasegawa and Hermann Sch{\"a}tzl and Sabine Gilch and Katsumi Doh-ura",

note = "Funding Information: This work was supported by grants from the Japan Society for the Promotion of Science [ 19K22479 (KT) and 19H03570 (KD)], and the Alberta Prion Research Institute Program [ 201700012 (SG, HS, KD)]. Publisher Copyright: {\textcopyright} 2021 Elsevier Inc.",

year = "2021",

month = jun,

day = "30",

doi = "10.1016/j.bbrc.2021.04.116",

language = "English",

volume = "560",

pages = "105--111",

journal = "Biochemical and Biophysical Research Communications",

issn = "0006-291X",

publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice

AU - Teruya, Kenta

AU - Oguma, Ayumi

AU - Arai, Keita

AU - Nishizawa, Keiko

AU - Iwabuchi, Sara

AU - Watanabe-Matsui, Miki

AU - Sakasegawa, Yuji

AU - Schätzl, Hermann

AU - Gilch, Sabine

AU - Doh-ura, Katsumi

N1 - Funding Information: This work was supported by grants from the Japan Society for the Promotion of Science [ 19K22479 (KT) and 19H03570 (KD)], and the Alberta Prion Research Institute Program [ 201700012 (SG, HS, KD)]. Publisher Copyright: © 2021 Elsevier Inc.

PY - 2021/6/30

Y1 - 2021/6/30

N2 - Anti-prion effects of cellulose ether (CE) are reported in rodents, but the molecular mechanism is fully unknown. Here, we investigated the genetic background of CE effectiveness by proteomic and genetic analysis in mice. Proteomic analysis in the two mouse lines showing a dramatic difference in CE effectiveness revealed a distinct polymorphism in the glia maturation factor β gene. This polymorphism was significantly associated with the CE effectiveness in various prion-infected mouse lines. Sequencing of this gene and its vicinity genes also revealed several other polymorphisms that were significantly related to the CE effectiveness. These polymorphisms are useful as genetic markers for finding more suitable mouse lines and exploring the genetic factors of CE effectiveness.

AB - Anti-prion effects of cellulose ether (CE) are reported in rodents, but the molecular mechanism is fully unknown. Here, we investigated the genetic background of CE effectiveness by proteomic and genetic analysis in mice. Proteomic analysis in the two mouse lines showing a dramatic difference in CE effectiveness revealed a distinct polymorphism in the glia maturation factor β gene. This polymorphism was significantly associated with the CE effectiveness in various prion-infected mouse lines. Sequencing of this gene and its vicinity genes also revealed several other polymorphisms that were significantly related to the CE effectiveness. These polymorphisms are useful as genetic markers for finding more suitable mouse lines and exploring the genetic factors of CE effectiveness.

KW - Cellulose ether

KW - Genetic analysis

KW - Glia maturation factor

KW - Prion

KW - Proportional hazards model

KW - Proteomics

UR - http://www.scopus.com/inward/record.url?scp=85105523202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105523202&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2021.04.116

DO - 10.1016/j.bbrc.2021.04.116

M3 - Article

C2 - 33984767

AN - SCOPUS:85105523202

SN - 0006-291X

VL - 560

SP - 105

EP - 111

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

ER -

Polymorphisms in glia maturation factor β gene are markers of cellulose ether effectiveness in prion-infected mice

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this